Synopsys Inc
MIL:1SNPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Synopsys Inc
MIL:1SNPS
|
US |
|
Linde PLC
NASDAQ:LIN
|
UK |
|
T
|
Traction Uranium Corp
CNSX:TRAC
|
CA |
|
S
|
STMicroelectronics NV
DUS:SGM
|
NL |
|
Orsted A/S
CSE:ORSTED
|
DK |
|
H
|
Hummingbird Resources PLC
OTC:HUMRF
|
UK |
|
Sirona Biochem Corp
XTSX:SBM
|
CA |
|
L
|
Lumentum Holdings Inc
SWB:LU2
|
US |
|
O
|
Orlen SA
PSE:PKN
|
PL |
|
Abivax SA
OTC:AAVXF
|
FR |
Wall St Price Targets
1SNPS Price Targets Summary
Synopsys Inc
According to Wall Street analysts, the average 1-year price target for 1SNPS is 460.59 EUR with a low forecast of 344.93 EUR and a high forecast of 577.16 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1SNPS's stock price target?
Price Target
460.59
EUR
According to Wall Street analysts, the average 1-year price target for 1SNPS is 460.59 EUR with a low forecast of 344.93 EUR and a high forecast of 577.16 EUR.
What is the Revenue forecast for Synopsys Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for Synopsys Inc?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 8 years is 24%.
What is the Net Income forecast for Synopsys Inc?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 8 years is 23%.
